PV Watch Daily
  • Home
  • Inspections & Compliance
  • AI & Digital PV
  • Careers
  • Regulatory Updates
  • Safety Signals
  • Explainers
  • News
  • About
Select Page
EMA PRAC Warns About Aseptic Meningitis Risk with Ixchiq Vaccine

EMA PRAC Warns About Aseptic Meningitis Risk with Ixchiq Vaccine

by Admin | Mar 14, 2026 | Safety Signals

EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) has completed its review of a safety signal involving aseptic meningitis with Ixchiq, the live attenuated chikungunya vaccine. EMA said PRAC has recommended an update to the product information to reflect the...
EMA’s PRAC Recommends Withdrawal of Levamisole Medicines: A Reminder of How Safety Reviews Can End

EMA’s PRAC Recommends Withdrawal of Levamisole Medicines: A Reminder of How Safety Reviews Can End

by Admin | Mar 13, 2026 | Safety Signals

In February 2026, the European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) concluded its safety review of levamisole-containing medicines and recommended that their marketing authorisations be withdrawn from the EU market. EMA said the review...
PAHO Calls for Stronger Pharmacovigilance After Reports of GLP-1 Misuse

PAHO Calls for Stronger Pharmacovigilance After Reports of GLP-1 Misuse

by Admin | Mar 13, 2026 | Safety Signals

The Pan American Health Organization has called for strengthened pharmacovigilance following reports of misuse involving GLP-1 medicines indicated for treating obesity in adults. PAHO published the warning on 3 March 2026, placing additional public-health and...
Next Entries »

Recent Posts

  • Why Regulators Are Building Always-On Safety Information Hubs
  • CVMP March 2026 Highlights Keep Veterinary Safety in View
  • EMA’s ESMP Training Push Signals More Structured Shortage Reporting
  • EMA Adds Anktiva to Additional Monitoring List in March 2026
  • Rabies Immunoglobulin Recall Follows Potency Stability Failure

Recent Comments

No comments to show.

PV Watch Daily

PV Watch Daily is a specialist news and intelligence platform covering pharmacovigilance, drug safety, regulatory updates, safety signals, inspections, AI in PV, compliance trends, and career developments across the global life sciences industry.

Quick Links

Home
Latest News
About
Contact
Newsletter
Editorial Policy

Categories

Regulatory Updates
Safety Signals
AI & Digital PV
Inspections & Compliance
Explainers
Careers
News

Get the Daily PV Brief

Subscribe for timely drug safety news, pharmacovigilance updates, safety alerts, and regulatory intelligence delivered to your inbox.

Subscribe Free

For inquiries: editor@pvwatchdaily.com

Powered by
►
Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.
None
►
Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.
None
►
Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.
None
►
Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.
None
►
Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
None
Powered by